Trials / Completed
CompletedNCT00172003
Effect of Zoledronic Acid in Patients With Renal Cell Cancer and Bone Metastasis
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Novartis Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
It is the aim of this clinical study to evaluate the skeletal-related event rate under therapy with zoledronic acid in patients with renal cell cancer having at least one cancer-related bone lesion.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Zoledronic acid |
Timeline
- Start date
- 2004-09-01
- Primary completion
- 2009-07-01
- Completion
- 2009-07-01
- First posted
- 2005-09-15
- Last updated
- 2016-11-18
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00172003. Inclusion in this directory is not an endorsement.